Health Condition 1: M791- Myalgia
Conditions
Interventions
Intervention1: Ozone injection: 8 ml of ozone gas with concentration of 15micro gm/ml at MTrP in affected trapezius, using a 24-gauge, 1.25 inch needle once weekly for 3 weeks.
Control Intervention1
Sponsors
ESI Institute of Pain Management
Eligibility
Inclusion criteria
Inclusion criteria: 1. Symptoms lasting >3 months despite conservative treatments including physiotherapy and medications. 2. Presence of active trigger points in the upper trapezius muscles (at least one). 3. Presence of at least one taut band on manual palpation. 4. NRS score 6 and above.
Exclusion criteria
Exclusion criteria: 1. Presence of any history of cervical radiculopathy or degenerative condition, 2. Presence of any surgery or trauma to the neck during last year, 3. Previous injection for MPS treatment during last 6 months, 4. Confirmed diagnosis of cognitive disorders, fibromyalgia, rheumatoid arthritis, and/or metabolic diseases like hypothyroidism and diabetes mellitus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain evaluated by the numeric pain rating scaleTimepoint: before the treatment and 4 weeks after the last injection. | — |
Secondary
| Measure | Time frame |
|---|---|
| neck disability index (NDI)Timepoint: before the treatment and 4 weeks after the last injection.;Range of motion (ROM) in neck lateral flexion movement measured using goniometryTimepoint: before the treatment and 4 weeks after the last injection.;Tissue Imaging Score based on gray scale imaging and vibration sonography with colour doppler imagingTimepoint: before the treatment and 4 weeks after the last injection. | — |
Countries
India
Contacts
Public ContactDr Subrata Goswami
ESI Institute of Pain Management
Outcome results
None listed